Roivant Sciences Ltd. ($ROIV)
Venker Eric โ President & Immunovant CEO
Shares
200,000
Price
$0.00
Total Value
$0.00
Nearby Earnings
Feb 6, 2026
EPS:Est: -0.27
Revenue:Est: $6.14M
Feb 9, 2026
EPS:Est: -0.27
Revenue:Est: $6.14M
Transaction Details
| Insider | Venker Eric |
|---|---|
| Title | President & Immunovant CEO |
| Transaction Date | Feb 13, 2026 |
| Expiration Date | Apr 19, 2032 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Stock Option (Right to Buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 13, 2026 |
| Shares Purchased | 200,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 5,044,834 |
| Derivative | Derivative |
| Accession Number | 0001635088-26-000017 |
| Document | View SEC Filing |